Global HIV prevention and treatment are at a crossroads, with major advances like long-acting injectables expanding access while funding cuts threaten progress. UNAIDS and WHO have issued ambitious ...
Merck is carving out its own place in the evolving HIV treatment space with an FDA approval for its Idvynso, a combination ...
Morning Overview on MSN
FDA approves Merck’s Idvynso combo pill for HIV treatment
The U.S. Food and Drug Administration on April 21, 2026, approved Merck’s Idvynso, a once-daily combination pill for HIV ...
Prism Health North Texas, a community health center, participated in clinical trials for Merck's new HIV treatment, Idvynso.
Len is a gamechanging drug to prevent HIV infections, priced by Gilead at $28,200. Limited drug is available at cost to ...
Despite highly effective HIV prevention drugs on the market, only a fraction of those at risk in the U.S. are taking them — or even know they're an option. It's called pre-exposure prophylaxis, or ...
Idvynso combines doravirine and islatravir in a once-daily tablet cleared for adults already suppressing HIV on stable ...
Just a few decades ago, human immunodeficiency virus, also known as HIV, was a death sentence for those who contracted ...
The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV’s spread among ...
AIDS Healthcare Foundation, a leading voice for AIDS patients, announced Tuesday it has launched a statewide media campaign ...
It could be possible to end HIV transmissions in Ireland — but to get there, we need action," said Pádraig Rice, the Social ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results